Cytotoxic and immune-sensitizing properties of nitric oxide-modified saquinavir in iNOS-positive human melanoma cells
Sanja Mijatović(University of Belgrade), Ferdinando Nicoletti(University of Catania), Antonio Di Cataldo(University of Catania), Katia Mangano(University of Catania), Djordje Miljković(University of Belgrade), Marco Donia(University of Copenhagen), Stanislava Stošić‐Grujičić(Institute for Biological Research “Siniša Stanković”), Marija Mojić(Northwell Health), Yousef Al‐Abed(Feinstein Institute for Medical Research), Danijela Maksimović‐Ivanić(Institute for Biological Research “Siniša Stanković”), Kai Cheng(Chinese Academy of Sciences), Gordana Timotijević(Northwell Health)
Cited by 30
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495